1.Peripheral iridotomy with combination of semiconductor laser 532 and YAG laser for primary angleclosure glaucoma
Chinese Journal of General Practitioners 2010;09(11):791-792
Peripheral iridotomy using combination of semiconductor laser 532 and YAG laser was performed on 35 eyes of 29 patients. All procedures were performed successfully and there was no significant change in visual acuity after treatment. One week after treatment, the intraocular pressure was 6.99 - 20.08 mm Hg(0.93 -2.67 kPa). Peripheral anterior chamber angles were all widened, no acceleration of lens opacity was observed. Combination of semiconductor laser and YAG laser peripheral iridotomy are safe and effective for angle closure treatment and can be performed in community hospitals.
2.Study of learning and memory function in D-galactose model mice improved by Sanchi Saponin Rg1 and its participating factors
Chinese Journal of Immunology 2000;0(11):-
Objective:To investigate the role of sanchi Saponin Rg1 in D-galactose -induced amnesic mice ,and its possible mechanism.Methods:D-galactose was injected by subcutaneous to establish the aging model, and with drug treatment group.The Y-maze tests was performed to evaluate the learning and memory function, spectrophotometry was used to measure abilities of anti-oxidation.ELISA was adopted to evaluate the level of IL-1? and IL-6. Then FCM was applied to assay the index of intracellular calcium and the percentage of neural cell apoptosis.Results:Compared with drug treatment group, the model mice reduced significantly activites of anti -oxidation , the overload of intracelluer calcium and the increase in apoptosis of neural cells as well as the inflammation factor.Conclusion:Sanchi Saponin Rg1 decreased in the content of inflammation factor , the index of intracellular calcium and the percentage of apoptosis in neural cells , possibly by enchancing the antioxidant function.
3.Quality standard of Yuquan Micropill
Chinese Traditional Patent Medicine 1992;0(08):-
AIM:To establish the quality standard of the composition of Yuquan Micropill(Radix Rehmanniae,Fructus Schisandrae Chinensis,Radix Puerariae lobatae,etc.). METHODS: The composition of Yuquan Micropill were identified by TLC and the content was determined by HPLC.Puerarin could be separated through Diamonsil~(TM) C_(18) column(5 ?m,250 mm?4.6 mm) with methanol-water(1.2∶3 by volume) as a mobile phase.The flow rate was 1.0 mL/min,the detection wavelength was set at 250 nm and the column temperature was maintained at 40 ℃.?-Schizandrin could be separated through Kromasil KR100-3.5 C_(18) column(100 mm?4.6 mm) with methanol-water(3.5∶1 by volume) as a mobile phase.The flow rate was 0.6 mL/min and the detection wavelength was set at 254 nm. RESULTS: The spots in the TLC were clear and could be well separated,the blank and adjuvant contrast could not be interfered.HPLC showed a good peak form,good resolution and could not be interfered by the foreign matter.The average recovery of puerarin was 99.24%,RSD=0.84%,RSD of precision was 0.95%,RSD of reproducibility was 0.86%,RSD of stability was 0.44%.The average recovery of ?-schizandrin was 99.74%,RSD=0.78%,RSD of precision was 1.89%,RSD of reproducibility was 1.76%,RSD of stability was 1.82%. CONCLUSION: The method is simple and has good resolution,strong specificity and good reproducibility,It can be used for the quality control of the composition of Yuquan Micropill.
4.Correlation between allergy and HLA genetic polymorphism
Chinese Pharmacological Bulletin 1986;0(04):-
Allergy increasingly threatens human health. At present, the molecular mechanisms of allergy have been one of the hot topics. It is believed that genetic factor and environmental factor play important roles in allergy. It is not surprising that particular HLA (human leukocyte antigen) class II alleles have been implicated in susceptility to allergic diseases and in restriction of the IgE responses to a variety of allergens. It will provide an original measure if the correlation between allergy and HLA genetic polymorphism was illuminated.
5.Correlation of HLA-DRB genetic locus with penicillin-specific IgE antibodies
Chinese Pharmacological Bulletin 1986;0(06):-
Aim To explore the correlation of positive specific IgE antibodies with penicillin allergy and HLA-DRB genetic polymorphism.Methods Sequence specific primer-polymerase chain reaction(PCR-SSP) was used to type human leucocyte antigen-DBR(HLA-DRB) alleles in 80 patients with positive IgE antibodies to penicillin and 101 healthy subjects without any allergic reactions.Results When different penicillin antigens were analyzed separately,the gene frequencies of DR16 in patients with positive BPO-IgE antibody and DR14.1 in patients with positive PVO-IgE antibody were found greatly lower than those of the control subjects(0 vs 8.62%,P
6.Effects of preoperative psychological state on the results of general anesthesia
Cancer Research and Clinic 2007;19(z1):66-67
Objective To study the effects of preoperative psychological state on calm time、recovery time and the level of pain about female tumer patients with general anesthesia.Methods We selected 105 female tumer patients whose ages were from 39 years to 66 years.They were divided into two groups according to SAS grade.We observed the calm time,recovery time and the VAS about the two groups.Results The calm time and reeovery time in disquieting group was significant longer than that of the normal group.There was a significant difference between group A and group B(P<0.01).Otherwise the grade of VAS after operation was significant greater than that of the normal group.Conclusion The disquieting preoperative psychological state would effect the results of general anesthesia.The anesthetist should pay attention to the visiting patients before operation.
7.Study on ligustrazine combined with chemotherapy in patients with relapsed or refractory non-Hodgkin's lymphoma
Journal of International Oncology 2010;37(5):397-400
Objective To explore the efficacy of ligustrazine combined with chemotherapy in patients with relapsed or refractory NHL and the relationships with P-gp expression. Methods 60 Patients were randomized into reversal agent group (ligustrazine + chemotherapy) and control group (chemotherapy) and the outcome was analysed. P- gp expression was analysed by flow cytometry. Subgroup analysis was conducted a ccording to P-gp expression. Results 56 patients could be evaluated. Progression -free survival (PFS) showed no statistical diference in two groups ( P = 0.065 1 ) ; reversal agent group had a higher overall response rate (ORR) than control group(P=0. 048).Subgroup analysis showed 41 patients had P-gp( +). The complete remission rate and complete remission uncertain rate of patients with P-gp( + ) in reversal agent group and control group were 33. 33% and 8. 70% , respectively, reversal agent group had a significant advantage ( P = 0. 048). Patients with P-gp( + ) in reversal agent group had a higher ORR than control group (61. 11% vs 26. 09% ,P =0.024). Kaplan-Meier survival curve and Log-rank test showed patients with P-gp( + ) in reversal agent group had longer PFS than control group (P =0.046 4). Blood pressure in a small number of patients received ligustrazine therapy decreased,and mitigated after reducing the dose. Conclusion Ligustrazine combined with chemotherapy can elevate response rate,prolong PFS with manageable toxicity and correlate to P-gp expression in relapsed or refractory NHL
8.Research progress of HGF/c-MET signaling pathway inhibitors in anti-pancreatic cancer
Journal of International Oncology 2017;44(4):304-306
Pancreatic cancer is one of the most malignant tumors.Targeted therapy has become an important part of the treatment of pancreatic cancer.The signaling pathways such as hepatocyte growth factor/c-MET (HGF/c-MET) signaling pathway, inhibition of which may exerts an antitumor effect, play extremely important roles in the occurrence and development of pancreatic cancer.Therefore, the research of HGF/c-MET targeted inhibitors opens up a new avenue for treatment of pancreatic cancer.
9.Clinical observation of rabeprazole combined with mosapride in the treatment of reflux esophagitis
Chinese Journal of Biochemical Pharmaceutics 2017;37(6):304-306
Objective To explore the clinical efficacy of rabeprazole combined with mosapride in the treatment of reflux esophagitis.MethodsThe clinical data of 315 patients with reflux esophagitis from December 2015 to December 2016 in our hospital were retrospectively analyzed, were randomly divided into two groups according to the time of admission.The control group (157 cases)was treated with rabeprazole, the observation group (158 cases) given rabeprazole combined with mosapride treatment.The clinical symptom scores before and after treatment, the effective rate of treatment, the quality of life before and one month after treatment and three months after treatment of two groups were compared.ResultsAfter treatment,the symptoms scores of the two groups were significantly lower than those before treatment, but the the scores in the observation group were significantly lower than those in the control group (P<0.05);The total effective rate was 96.2% in the observation group, which was significantly higher than that in the control group (79.0%), the difference between the two groups was statistically significant (P<0.05);The quality of life scores of the two groups were significantly higher than that before treatment, but the scores of one months after treatment and three months after treatment in observation group were significantly higher than those in control group (P<0.05).ConclusionReflux esophagitis with rabeprazole combined with mosapride treatment is significant,can better improve the clinical symptoms of patients, improve the treatment efficiency, and improve the quality of life of patients.
10.Pharmaceutical Care for One Patient with Acute Promyelocytic Leukemia Complicated with Retinoic Acid Syndrome
China Pharmacist 2017;20(3):520-521
Objective:To investigate the role of clinical pharmacists in the therapy for a patient with acute promyelocytic leukemi-a. Methods:Clinical pharmacists participated in the treatment process of a patient with acute promyelocytic leukemia complicated with retinoic acid syndrome after tretinoin therapy. The rational treatment plan was put forward according to the literatures,the characteristics of drugs and the general situation of the patient. Results: Promising therapeutic effect was obtained,and the patient was discharged from the hospital. Conclusion:Clinical pharmacists play an active role in improving rational drug use and providing better individual-ized treatment for patients.